Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA

NCT05814224 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

164

Enrollment

OTHER

Sponsor class

Conditions

Hormone Receptor Positive Breast Carcinoma
Breast Neoplasms
Neoplasms, Breast
Breast Diseases
Antineoplastic Agents
Aromatase Inhibitors
ESR1 Gene Mutation

Interventions

DIAGNOSTIC_TEST: Liquid biopsy and CT scan

Sponsor

Centro di Riferimento Oncologico - Aviano